dromlakhani Repeat radiograph to monitor osteolytic lesions
STEP 1 — Gather Information
Collect baseline plain radiograph confirming an osteolytic lesion, date of radiological diagnosis, current biochemical markers (serum ALP, P1NP, CTx/NTx), presence of bone pain, and current antiresorptive therapy. Proceed to assess timing since diagnosis.
STEP 2 — Rule In / Rule Out
Determine whether a definitive osteolytic lesion of Paget’s disease is present on the baseline radiograph. If yes, proceed to step 3; if no, consider alternative diagnoses and do not schedule repeat X‑ray for Paget’s lesion monitoring.
STEP 3 — Classify or Stratify
Assess whether approximately 12 months have elapsed since the radiological diagnosis. If yes, proceed to step 4; if less than 12 months, obtain a repeat X‑ray only if biochemical markers are persistently elevated or bone pain has worsened.
STEP 4 — Decide
Obtain a repeat radiograph of the affected region. If the lesion shows improvement, continue current therapy and schedule the next X‑ray in 1–2 years if markers remain stable; if the lesion shows worsening or no change, consider intensifying antiresorptive therapy or investigating alternative causes; if biochemical markers remain elevated or bone pain persists despite stable imaging, consider earlier repeat imaging or additional workup.
Clinical Guardrails / Mimics / Pitfalls
Do not repeat X‑ray solely on the basis of normal alkaline phosphatase when bone pain persists; avoid using radiographs to monitor diffuse polyostotic disease without focal lesions; do not delay repeat imaging beyond 2 years if markers rise or pain develops; do not substitute plain X‑ray for bone scintigraphy when assessing overall disease extent.
Concrete Clinical Example
A 70‑year‑old woman with an osteolytic lesion in the iliac crest diagnosed 14 months ago, on oral alendronate, reports mild aching pain and has an elevated ALP (120 U/L). Repeat pelvic X‑ray shows no significant change in lesion size; she is switched to intravenous zoledronate and her symptoms improve.
Source: Paget’s Disease of Bone: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, doi:10.1210/jc.2014-2910